US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

223.00

-4.7500-2.09%

Post-market: 223.660.6600+0.30%19:57 EDT

Volume:804.93K

Turnover:174.45M

Market Cap:562.96M

PE:- -

High:224.85

Open:221.88

Low:208.28

Close:227.75

52wk High:341.93

52wk Low:102.35

Shares:2.52M

Float Shares:2.52M

Volume Ratio:1.53

T/O Rate:31.88%

Dividend:0.91

Dividend Rate:0.41%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Emeis Executes Share Buyback as Mission-Driven Care Group Expands Role in Vulnerable Healthcare

Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), Pacira Pharmaceuticals (PCRX)

Rezolute: FDA’s Constructive Stance on Ersodetug and Strategic Dual-Indication Path Support Unchanged $10 Price Target and Buy Rating

MoonLake Immunotherapeutics Could Win FDA Approval for Sonelokimab by Year-End 2027, Wedbush Says

MT Newswires Live

Analysts’ Top Healthcare Picks: GE Healthcare Technologies Inc (GEHC), Harrow Health (HROW)

Analysts’ Top Healthcare Picks: Novartis (NVS), Crescent Biopharma (CBIO)

Roth sees second FDA panel as possibility for Capricor

Analysts Conflicted on These Healthcare Names: Capricor Therapeutics (CAPR), Alector (ALEC) and Irhythm Technologies (IRTC)

Analysts Are Bullish on Top Healthcare Stocks: Liquidia Technologies (LQDA), Kodiak Sciences (KOD)

Abbott Laboratories Receives FDA Approval to Include Interactive Features in CardioMEMS Heart Monitor

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Elutia (ELUT) and Evaxion Biotech (EVAX)

Analysts Offer Insights on Healthcare Companies: Trulieve Cannabis (TRLV) and Enovis (ENOV)

Endovia Health Sciences announces FDA minor-use determination for CannEpil

Benitec Biopharma says BB-301 pivotal still on track for mid-2027

Wall Street Analysts Are Bullish on Top Healthcare Picks

Sector Update: Healthcare

MT Newswires Live

RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab

Analysts Conflicted on These Healthcare Names: Alignment Healthcare (ALHC), Tilray (TLRY) and Fractyl Health, Inc. (GUTS)

Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference

Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/LABU/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":223,"timestamp":1791489600000,"preClose":227.75,"halted":0,"volume":804929,"hourTrading":{"tag":"盘后","latestPrice":223.66,"preClose":223,"latestTime":"19:57 EDT","volume":4124,"amount":918785.7173,"timestamp":1791503872443,"change":0.66,"changeRate":0.00296,"amplitude":0.008427},"delay":0,"changeRate":-0.020856201975850714,"floatShares":2524486,"shares":2524486,"eps":0,"marketStatus":"Closed","change":-4.75,"latestTime":"10-08 16:00:00 EDT","open":221.88,"high":224.8479,"low":208.28,"amount":174447835.0605,"amplitude":0.072746,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":227.75,"sharesOutstanding":3074486,"nav":227.52,"aum":597123938.28,"dividendRate":0.004085,"bidAskSpread":0.003146,"preHourTrading":{"tag":"盘前","latestPrice":220.18,"preClose":227.75,"latestTime":"09:29 EDT","volume":6169,"amount":1385605.45651,"timestamp":1791466199999,"change":-7.57,"changeRate":-0.033238,"amplitude":0.038727},"postHourTrading":{"tag":"盘后","latestPrice":223.66,"preClose":223,"latestTime":"19:57 EDT","volume":4124,"amount":918785.7173,"timestamp":1791503872443,"change":0.66,"changeRate":0.00296,"amplitude":0.008427},"volumeRatio":1.526101,"impliedVol":1.0277,"impliedVolPercentile":0.9004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2524486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.526101,"shares":2524486,"dividePrice":0.911,"high":224.8479,"amplitude":0.072746,"preClose":227.75,"low":208.28,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":223,"eps":0,"divideRate":0.004085,"volume":804929,"delay":0,"ttmEps":0,"open":221.88,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":249.65,"twentyDayClose":266,"sixtyDayClose":277.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673086435","title":"Emeis Executes Share Buyback as Mission-Driven Care Group Expands Role in Vulnerable Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2673086435","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673086435?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:51","pubTimestamp":1791219108,"startTime":"0","endTime":"0","summary":"Orpea SA ( ($FR:EMEIS) ) has provided an update. Emeis, a European healthcare and care-services group, operates a broad network of mental health an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/emeis-executes-share-buyback-as-mission-driven-care-group-expands-role-in-vulnerable-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/emeis-executes-share-buyback-as-mission-driven-care-group-expands-role-in-vulnerable-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGCV","BK4137","BK4585","GXF","XBI","EPV","LU0029874061.USD","HCSG","VHT","BK4588","IXJ","BK4581","LU0128526141.USD","TCAF","LABU","DBEU","XLV","NOBL","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673086129","title":"Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), Pacira Pharmaceuticals (PCRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673086129","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673086129?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:50","pubTimestamp":1791219048,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immunome (IMNM) and Pacira Pharmaceuticals (PCRX) wi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immunome-imnm-pacira-pharmaceuticals-pcrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immunome-imnm-pacira-pharmaceuticals-pcrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4139","BK4581","IMNM","PCRX","XBI","BK4585","BK4563","LU0029874061.USD","LU0128526141.USD","BK4588","BK4137","LABU","BK4007","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085682","title":"Rezolute: FDA’s Constructive Stance on Ersodetug and Strategic Dual-Indication Path Support Unchanged $10 Price Target and Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085682","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085682?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:35","pubTimestamp":1791214547,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on Rezolute today and set a price target of $10.00. Douglas Tsao has given his Buy rat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/rezolute-fdas-constructive-stance-on-ersodetug-and-strategic-dual-indication-path-support-unchanged-10-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/rezolute-fdas-constructive-stance-on-ersodetug-and-strategic-dual-indication-path-support-unchanged-10-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673858060","title":"MoonLake Immunotherapeutics Could Win FDA Approval for Sonelokimab by Year-End 2027, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2673858060","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673858060?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:26","pubTimestamp":1791214007,"startTime":"0","endTime":"0","summary":"MoonLake Immunotherapeutics  could receive US Food and Drug Administration approval for sonelokimab as a treatment for hidradenitis suppurativa by year-end 2027, with the completed BLA submission representing a key milestone, Wedbush Securities said in a Monday note.The company has completed its biologics license application, or BLA, for sonelokimab and has also requested a priority review designation, the brokerage said. The FDA's acceptance of the BLA should be a positive catalyst for MoonLake, regardless of review designation, according to the note.MoonLake's 52-week data from two phase 3 studies of sonelokimab showed the product candidate has \"at least comparable efficacy\" to bimekizumab, an approved treatment for the same indication, the investment firm said.The brokerage added that a decision on the filing should be released within 60 days, by the end of November, and that the review designation should be confirmed within 74 days of filing, based on the review timeline.Wedbush ha","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LABU","BK4139","BK4588","MLTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673083041","title":"Analysts’ Top Healthcare Picks: GE Healthcare Technologies Inc (GEHC), Harrow Health (HROW)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673083041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673083041?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:00","pubTimestamp":1791212426,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on GE Healthcare Technologies Inc (GEHC) and Harrow Hea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-ge-healthcare-technologies-inc-gehc-harrow-health-hrow-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-ge-healthcare-technologies-inc-gehc-harrow-health-hrow-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","LU1551013425.SGD","LU1093756325.SGD","BK4566","LU1119994496.HKD","LU0210536198.USD","GE","MISL","LU2168564149.EUR","BK4581","BK4543","LU0943347566.SGD","LU2264538146.SGD","LU0640476718.USD","LU0354030438.USD","BK4206","LU0820561909.HKD","LU0820562030.AUD","LU1064131342.USD","LU2168564065.EUR","BK4501","HROW","BK4007","LABU","BK4585","LU2168564495.EUR","TRUI","LGHT","LU0077335932.USD","PPA","LU2087625088.SGD","LU1066051498.USD","XAR","XLV","GEHC","LU0353189680.USD","LU1066051225.USD","LU0353189763.USD","LU1093756168.USD","UXI","XBI","BK4588","LU2168564222.USD","NATO","BK4187","LU1551013342.USD","ITA","DFEN","EXI","LU2896262040.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673908348","title":"Analysts’ Top Healthcare Picks: Novartis (NVS), Crescent Biopharma (CBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673908348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673908348?lang=en_us&edition=fundamental","pubTime":"2026-10-05 22:40","pubTimestamp":1791211208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Novartis (NVS) and Crescent Biopharma (CBIO) with bu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-novartis-nvs-crescent-biopharma-cbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-novartis-nvs-crescent-biopharma-cbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4578","BK4585","PPH","BK4532","IE00BJJMRZ35.SGD","LU0128526141.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LABU","BK4139","MEDX","BK4581","LU0070302665.USD","IE00B2B36J28.USD","CBIO","BK4007","NVS","XLV","BK4137","LU0211331839.USD","LU0029874061.USD","IE00BJT1NW94.SGD","LU0320765489.SGD","LU0208291251.USD","IE00B4R5TH58.HKD","XBI","IE0009355771.USD","BK4588","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673083566","title":"Roth sees second FDA panel as possibility for Capricor","url":"https://stock-news.laohu8.com/highlight/detail?id=2673083566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673083566?lang=en_us&edition=fundamental","pubTime":"2026-10-05 22:25","pubTimestamp":1791210319,"startTime":"0","endTime":"0","summary":"Roth Capital believes Capricor Therapeutics (CAPR)’ open label extension data this morning strengthens deramiocel’s upper-limb efficacy. However, e...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roth-sees-second-fda-panel-as-possibility-for-capricor-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roth-sees-second-fda-panel-as-possibility-for-capricor-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4585","CAPR","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673708808","title":"Analysts Conflicted on These Healthcare Names: Capricor Therapeutics (CAPR), Alector (ALEC) and Irhythm Technologies (IRTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673708808","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673708808?lang=en_us&edition=fundamental","pubTime":"2026-10-05 22:10","pubTimestamp":1791209418,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Capricor Therapeutics (CAPR), Alector (ALEC) and I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-capricor-therapeutics-capr-alector-alec-and-irhythm-technologies-irtc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-capricor-therapeutics-capr-alector-alec-and-irhythm-technologies-irtc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","IRTC","LABU","HCSG","CAPR","XBI","BK4585","BK4082","LU0128526141.USD","BK4139","BK4563","BK4137","BK4588","BK4581","ALEC","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673508808","title":"Analysts Are Bullish on Top Healthcare Stocks: Liquidia Technologies (LQDA), Kodiak Sciences (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673508808","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673508808?lang=en_us&edition=fundamental","pubTime":"2026-10-05 22:00","pubTimestamp":1791208824,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Liquidia Technologies (LQDA), Kodiak Sciences (KOD) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-liquidia-technologies-lqda-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-liquidia-technologies-lqda-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0128526141.USD","BK4581","BK4007","BK4137","LABU","BK4585","XBI","XLV","LQDA","BK4139","BK4505","KOD","LU0029874061.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673651088","title":"Abbott Laboratories Receives FDA Approval to Include Interactive Features in CardioMEMS Heart Monitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2673651088","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673651088?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:58","pubTimestamp":1791208718,"startTime":"0","endTime":"0","summary":"Abbott Laboratories  said Monday that it has received US Food and Drug Administration approval for technology that provides updates directly to patients through its CardioMEMS HF System.The company said the technology allows doctors to share daily heart pressure readings directly with patients between office visits. It said the technology also provides the ability to send medication adjustment instructions to patients' smartphones and measures pressure through an implanted sensor in the pulmonary artery.Abbott said it plans to make CardioGuide HF App and Dynamic Treatment Plan available later in the year.Price: 97.69, Change: +0.19, Percent Change: +0.19","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009355771.USD","LU1983299246.USD","SGXZ23171101.USD","LU0058720904.USD","LU0432979614.USD","LU0070302665.USD","BK4082","TMED","LU1670628061.USD","IE00BFTCPJ56.SGD","BK4588","LU0114720955.EUR","LU2211815571.USD","IE00B2B36J28.USD","LABU","LU0211331839.USD","LU0868494617.USD","LU0170899867.USD","SGXZ41872573.SGD","SG9999002232.USD","ABT.AU","PJP","IHI","LU2237957811.SGD","LU1691799644.USD","LU0882574055.USD","BK4533","SG9999002224.SGD","BK4566","LU1914381329.SGD","BK4585","IE00BJT1NW94.SGD","ABT","LU0122379950.USD","LU1061106388.HKD","LU2089984988.USD","LU0234572021.USD","BK4568","LU2133065610.SGD","LU1989763427.SGD","BK4504","LU1989763690.USD","LU1721429402.USD","LU2112291526.USD","BK4592","LU2237957902.USD","LU1023059063.AUD","LU0208291251.USD","BK4581","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673889020","title":"Analysts Offer Insights on Healthcare Companies: Elutia (ELUT) and Evaxion Biotech (EVAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673889020","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673889020?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:50","pubTimestamp":1791208208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Elutia (ELUT) and Evaxion Biotech (EVAX) with bullis...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-elutia-elut-and-evaxion-biotech-evax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-elutia-elut-and-evaxion-biotech-evax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","EVAX","LU0029874061.USD","LU0128526141.USD","BK4581","BK4137","XLV","BK4585","XBI","BK4139","HCSG","LABU","ELUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673888850","title":"Analysts Offer Insights on Healthcare Companies: Trulieve Cannabis (TRLV) and Enovis (ENOV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673888850","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673888850?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:30","pubTimestamp":1791207023,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Trulieve Cannabis (TRLV) and Enovis (ENOV) with bull...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trulieve-cannabis-trlv-and-enovis-enov-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trulieve-cannabis-trlv-and-enovis-enov-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["YOLO","LABU","XLV","MSOS","CNBS","XBI","IE00B19Z6F94.USD","HCSG","TRLV","BK4082","LU2065732104.USD","BK4007","MJ","BK4588","ENOV","LU0128526141.USD","TOKE","LU0029874061.USD","BK4581","IE0034390439.USD","BK4137","BK4585","WEED","MSOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673001207","title":"Endovia Health Sciences announces FDA minor-use determination for CannEpil","url":"https://stock-news.laohu8.com/highlight/detail?id=2673001207","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673001207?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:15","pubTimestamp":1791206114,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences (EDVA) announced the FDA Center for Veterinary Medicine determined that the proposed use of CannEpil, an investigational CB...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/endovia-health-sciences-announces-fda-minor-use-determination-for-cannepil-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/endovia-health-sciences-announces-fda-minor-use-determination-for-cannepil-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585","EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673001267","title":"Benitec Biopharma  says BB-301 pivotal still on track for mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2673001267","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673001267?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:10","pubTimestamp":1791205831,"startTime":"0","endTime":"0","summary":"Benitec announced formal FDA feedback following a Type C meeting in Q3. Discussions on an open-label, single-arm pivotal study for BB-301 are ongoi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/benitec-biopharma-says-bb-301-pivotal-still-on-track-for-mid-2027-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/benitec-biopharma-says-bb-301-pivotal-still-on-track-for-mid-2027-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BBUL","LABU","BNTC","BK4547","BK4585","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673700119","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2673700119","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673700119?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:10","pubTimestamp":1791205824,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alterity Therapeutics (ATHE), Verastem (VSTM) and Ge...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-371?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-371?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0128526141.USD","XBI","BK4139","BK4585","VSTM","ATHE","BK4588","HCSG","BK4137","BK4581","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673700351","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2673700351","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673700351?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:01","pubTimestamp":1791205283,"startTime":"0","endTime":"0","summary":"Healthcare stocks were steady pre-bell Monday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  down a slight 0.1%.Vaxcyte  shares were up more than 57% after the company said its experimental VAX-31 drug candidate met all pre-specified primary endpoints across age groups studies, compared with Prevnar 20 and/or Capvaxive, in a phase 3 trial of the invasive pneumococcal disease and pneumococcal pneumonia treatment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","XBI","BK4585","PCVX","BK4581","HCSG","BK4139","IE0009354923.USD","LU0128526141.USD","XLV","LU0029874061.USD","LABU","BK4588","BK4137","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673311700","title":"RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab","url":"https://stock-news.laohu8.com/highlight/detail?id=2673311700","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673311700?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:00","pubTimestamp":1791205200,"startTime":"0","endTime":"0","summary":"License of up to 20 years and reciprocal share exchange would entitle RYET to a 10% royalty on qualifying technology receipts and 560,000 BGLC shares as Malaysia accelerates public healthcare digitali","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374576/0/en/ryet-to-enter-malaysian-healthcare-through-exclusive-cogni-ai-license-to-bionexus-gene-lab.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTHR","LU0128526141.USD","LU0029874061.USD","NOBL","HCSG","BK4204","BK4588","CHAT","BGLC","IXJ","XLV","RYET","CGCV","BK4550","BK4581","BK4585","AIPO","QTOC","BK4104","BK4137","LABU","AGIX","ARTY","TCAF","VHT","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673270706","title":"Analysts Conflicted on These Healthcare Names: Alignment Healthcare (ALHC), Tilray (TLRY) and Fractyl Health, Inc. (GUTS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673270706","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673270706?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:50","pubTimestamp":1791204627,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alignment Healthcare (ALHC), Tilray (TLRY) and Fra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alignment-healthcare-alhc-tilray-tlry-and-fractyl-health-inc-guts-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alignment-healthcare-alhc-tilray-tlry-and-fractyl-health-inc-guts-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALHC","BK4557","GUTS","LABU","BK4585","BK4082","BK4581","XBI","TLRY","BK4547","BK4588","BK4007","XLV","BK4596","BK4539","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673970740","title":"Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2673970740","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673970740?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:45","pubTimestamp":1791204300,"startTime":"0","endTime":"0","summary":"LOS ANGELES, CA, Oct.  05, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a global leader in AL Amyloidosis, today announced that it will present at th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374561/0/en/immix-biopharma-to-participate-in-the-45th-annual-j-p-morgan-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1989772923.USD","LU1244550577.SGD","LU2028103732.USD","IE00BZ1G4Q59.USD","XBI","ODD","LU0006306889.USD","BK4127","LU0795875086.SGD","LU0390134368.USD","LU1988902786.USD","LU2264538146.SGD","LU1162221912.USD","BK4581","BK4183","LU0128526141.USD","LU0106261372.USD","LU1989772840.SGD","LU1668664300.SGD","LU0528227936.USD","LU1244550494.USD","LU1548497426.USD","LU0106831901.USD","LU2111349929.HKD","LU1732800096.USD","LU0158827781.USD","LU0225283273.USD","LU0795875169.SGD","HCSG","XLV","LU1074936037.SGD","LU1064131342.USD","IE0009354923.USD","LU2089284900.SGD","BK4516","LU2487616109.SGD","LU2347655156.SGD","KBWB","LU2089283258.USD","LU1791710582.SGD","BK4534","LU2023251221.USD","LU1363072403.SGD","LU1791710400.SGD","LU1244550221.USD","LABU","BK4137","IAI","IE00B3S45H60.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673707408","title":"Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2673707408","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673707408?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:45","pubTimestamp":1791204300,"startTime":"0","endTime":"0","summary":"Companies to Meet Formally with FDA’s Center for Veterinary Medicine on November 19th for Pre-Submission Conference; U.S. Manufacturing Strategy Underway to Support Potential 2027 Veterinary Product L","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374563/0/en/endovia-and-lupvindol-biosciences-announce-fda-determination-that-cannepil-for-canine-bone-cancer-pain-qualifies-as-a-minor-use-establishing-eligibility-for-conditional-approval-pa.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBD","BK4588","EES","LU0130103400.USD","LU1201861165.SGD","LU0963586101.USD","LU0648000940.SGD","LU2324357040.USD","LABU","BK4113","BK4585","BK4185","THC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":8,"totalSize":426,"code":"91000000","status":"200"}]}}